Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism 5-HT2C receptor antagonists(Serotonin 2c (5-HT2c) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H23NO3 |
InChIKeyXKPFAVXGYLJDLN-KQKSKQCLSA-N |
CAS Registry204650-40-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anxiety Disorders | Phase 1 | - | - | |
| Depressive Disorder | Phase 1 | - | - | |
| Migraine Disorders | Phase 1 | - | - | |
| Sleep Wake Disorders | Phase 1 | - | - |





